PL2611776T3 - Sposób wytwarzania pośredniego związku do syntezy leku - Google Patents
Sposób wytwarzania pośredniego związku do syntezy lekuInfo
- Publication number
- PL2611776T3 PL2611776T3 PL11822081T PL11822081T PL2611776T3 PL 2611776 T3 PL2611776 T3 PL 2611776T3 PL 11822081 T PL11822081 T PL 11822081T PL 11822081 T PL11822081 T PL 11822081T PL 2611776 T3 PL2611776 T3 PL 2611776T3
- Authority
- PL
- Poland
- Prior art keywords
- production method
- intermediate compound
- synthesizing
- medicament
- synthesizing medicament
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20100086619 | 2010-09-03 | ||
| EP11822081.3A EP2611776B1 (en) | 2010-09-03 | 2011-08-25 | Production method of intermediate compound for synthesizing medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2611776T3 true PL2611776T3 (pl) | 2017-06-30 |
Family
ID=45023417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11822081T PL2611776T3 (pl) | 2010-09-03 | 2011-08-25 | Sposób wytwarzania pośredniego związku do syntezy leku |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US8741927B2 (pl) |
| EP (1) | EP2611776B1 (pl) |
| JP (1) | JP5705985B2 (pl) |
| KR (1) | KR101378984B1 (pl) |
| CN (1) | CN103080088B (pl) |
| AP (1) | AP3270A (pl) |
| AR (1) | AR082881A1 (pl) |
| AU (1) | AU2011296767B2 (pl) |
| BR (1) | BR112013004988B1 (pl) |
| CA (1) | CA2810393C (pl) |
| CL (1) | CL2013000589A1 (pl) |
| CO (1) | CO6700826A2 (pl) |
| DK (1) | DK2611776T3 (pl) |
| EA (1) | EA022500B1 (pl) |
| EC (1) | ECSP13012471A (pl) |
| ES (1) | ES2607089T3 (pl) |
| HK (1) | HK1184787A1 (pl) |
| HU (1) | HUE032484T2 (pl) |
| IL (1) | IL224954B (pl) |
| MA (1) | MA34490B1 (pl) |
| MX (1) | MX2013002277A (pl) |
| MY (1) | MY157423A (pl) |
| NZ (1) | NZ607694A (pl) |
| PE (1) | PE20131128A1 (pl) |
| PL (1) | PL2611776T3 (pl) |
| PT (1) | PT2611776T (pl) |
| SG (1) | SG188329A1 (pl) |
| SI (1) | SI2611776T1 (pl) |
| TW (1) | TWI438188B (pl) |
| UA (1) | UA107721C2 (pl) |
| UY (1) | UY33589A (pl) |
| WO (1) | WO2012030106A2 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2995612A1 (en) * | 2014-09-12 | 2016-03-16 | Université de Strasbourg | Novel non-natural amino acids, their process of preparation and uses thereof |
| KR102068754B1 (ko) * | 2017-04-20 | 2020-01-21 | 주식회사 엘지화학 | 의약품 합성용 중간체 화합물의 제조 방법 |
| RU2742765C1 (ru) * | 2017-09-28 | 2021-02-10 | ЭлДжи КЕМ, ЛТД. | Способ получения промежуточного соединения для синтеза лекарственного средства |
| MX2020003543A (es) * | 2017-09-28 | 2020-07-29 | Lg Chemical Ltd | Metodo de produccion de un compuesto intermediario para sintetizar un medicamento. |
| CN111247127B (zh) * | 2017-11-16 | 2024-02-06 | 株式会社Lg化学 | 用于合成药物的中间体化合物的生产方法 |
| WO2019098551A1 (ko) * | 2017-11-16 | 2019-05-23 | 주식회사 엘지화학 | 의약품 합성용 중간체 화합물의 제조 방법 |
| CN113861061A (zh) * | 2021-10-25 | 2021-12-31 | 成都市科隆化学品有限公司 | 一种不含无机铵盐的氨基酸酰胺盐酸盐及其合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4456768A (en) * | 1980-10-08 | 1984-06-26 | The University Of Chicago | Chemical synthesis |
| US5556982A (en) | 1985-01-14 | 1996-09-17 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
| DE3705272A1 (de) | 1987-02-19 | 1988-09-01 | Basf Ag | Verfahren zur reduktion von mono- und dicarbonsaeuren |
| US5417023A (en) * | 1993-12-27 | 1995-05-23 | Mandish; Theodore O. | Building panel apparatus and method |
| IL151018A0 (en) * | 2000-03-17 | 2003-02-12 | Bristol Myers Squibb Pharma Co | Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| TWI357902B (en) * | 2005-04-01 | 2012-02-11 | Lg Life Science Ltd | Dipeptidyl peptidase-iv inhibiting compounds, meth |
| CA2660397A1 (en) * | 2006-08-09 | 2008-02-21 | Smithkline Beecham Corporation | Pyrrolidinone anilines as progesterone receptor modulators |
| KR20080071476A (ko) * | 2007-01-30 | 2008-08-04 | 주식회사 엘지생명과학 | 신규한 디펩티딜 펩티데이즈 ｉｖ(ｄｐｐ-ｉｖ) 저해제 |
| AU2008341352B2 (en) * | 2007-12-21 | 2013-08-01 | Lg Chem, Ltd. | Dipeptidyl peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent |
-
2011
- 2011-08-25 CN CN201180041893.9A patent/CN103080088B/zh active Active
- 2011-08-25 ES ES11822081.3T patent/ES2607089T3/es active Active
- 2011-08-25 PT PT118220813T patent/PT2611776T/pt unknown
- 2011-08-25 NZ NZ607694A patent/NZ607694A/en unknown
- 2011-08-25 SG SG2013014931A patent/SG188329A1/en unknown
- 2011-08-25 MA MA35699A patent/MA34490B1/fr unknown
- 2011-08-25 AU AU2011296767A patent/AU2011296767B2/en active Active
- 2011-08-25 PE PE2013000351A patent/PE20131128A1/es active IP Right Grant
- 2011-08-25 MY MYPI2013000673A patent/MY157423A/en unknown
- 2011-08-25 AP AP2013006763A patent/AP3270A/xx active
- 2011-08-25 DK DK11822081.3T patent/DK2611776T3/en active
- 2011-08-25 PL PL11822081T patent/PL2611776T3/pl unknown
- 2011-08-25 JP JP2013527003A patent/JP5705985B2/ja active Active
- 2011-08-25 MX MX2013002277A patent/MX2013002277A/es active IP Right Grant
- 2011-08-25 CA CA2810393A patent/CA2810393C/en active Active
- 2011-08-25 UA UAA201302600A patent/UA107721C2/ru unknown
- 2011-08-25 HU HUE11822081A patent/HUE032484T2/en unknown
- 2011-08-25 EA EA201390336A patent/EA022500B1/ru unknown
- 2011-08-25 US US13/820,197 patent/US8741927B2/en active Active
- 2011-08-25 BR BR112013004988-0A patent/BR112013004988B1/pt active IP Right Grant
- 2011-08-25 SI SI201131045A patent/SI2611776T1/sl unknown
- 2011-08-25 EP EP11822081.3A patent/EP2611776B1/en active Active
- 2011-08-25 WO PCT/KR2011/006260 patent/WO2012030106A2/en active Application Filing
- 2011-09-02 TW TW100131640A patent/TWI438188B/zh active
- 2011-09-02 AR ARP110103214A patent/AR082881A1/es active IP Right Grant
- 2011-09-02 KR KR1020110089110A patent/KR101378984B1/ko active IP Right Grant
- 2011-09-02 UY UY0001033589A patent/UY33589A/es unknown
-
2013
- 2013-02-27 IL IL224954A patent/IL224954B/en active IP Right Grant
- 2013-03-01 EC ECSP13012471 patent/ECSP13012471A/es unknown
- 2013-03-01 CL CL2013000589A patent/CL2013000589A1/es unknown
- 2013-03-01 CO CO13042032A patent/CO6700826A2/es unknown
- 2013-10-31 HK HK13112271.0A patent/HK1184787A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268953B (en) | A process to form cycloalkylcarboxamido indole compounds | |
| PL2609120T3 (pl) | Ulepszony sposób wytwarzania sugammadeksu | |
| HK1178688A1 (en) | Process for production of connected structure | |
| IL248217B (en) | A method for the production of inganol-3-englate | |
| IL221299A (en) | A process for the preparation of Rifaximine pallimorphic configuration | |
| IL221170A0 (en) | Processes of synthesizing dihydropyridophthalazinone derivatives | |
| PL2632930T3 (pl) | Sposób pozyskiwania ligniny | |
| PL2542531T3 (pl) | Sposób syntezy fipronilu | |
| HK1184787A1 (en) | Production method of intermediate compound for synthesizing medicament | |
| EP2660195A4 (en) | PROCESS FOR PREPARING A COMPOUND WITH CHALKOPYRITE STRUCTURE | |
| EP2623580A4 (en) | PROCESS FOR PRODUCING BETA-SIALON | |
| IL222474A0 (en) | Method of synthesis | |
| EP2468799A4 (en) | PROCESS FOR PRODUCING MODIFIED POLYSILOXANE COMPOUND | |
| EP2522648A4 (en) | METHOD FOR PRODUCING A DIFLUORCYCLOPROPAN COMPOUND | |
| EP2423212A4 (en) | PROCESS FOR PREPARING A 2-AZAADAMANTAN COMPOUND FROM A BICYCLOCARBAMATE COMPOUND | |
| EP2518061A4 (en) | PROCESS FOR PRODUCING EPOXY COMPOUND | |
| EP2535322A4 (en) | PROCESS FOR SYNTHESIZING ACROLEIN | |
| HK1171020A1 (en) | Process for preparation of pyrimidinylpyrazole compounds | |
| EP2537851A4 (en) | PROCESS FOR PREPARING B-GLYCOSIDE COMPOUNDS | |
| EP2578568A4 (en) | PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED FLUOROPYRROLIDINE DERIVATIVES | |
| EP2583960A4 (en) | METHOD FOR MANUFACTURING CYCLIC CARBODIIMIDE COMPOSITION INTERMEDIATE | |
| EP2546235A4 (en) | PROCESS FOR THE PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS | |
| HK1181031A1 (zh) | 合成方法 | |
| PL391495A1 (pl) | Sposób wytwarzania 3ß, 11α-dihydroksy-17a-oxa-D-homo-5α-androstan-17-onu | |
| EP2657222A4 (en) | METHOD FOR PRODUCING A BETA-AMINOCARBONYL COMPOUND |